medigraphic.com
ISSN 2078-7170 (Electronic)

2012, Number 1

<< Back Next >>

CorSalud 2012; 4 (1)

Acute myocardial infarction at the comprehensive diagnostic medical centers of Trujillo State

Ramos GHL, Concepción GV

Language: Spanish
References: 31
Page: 39-48
PDF size: 163.12 Kb.


ABSTRACT

Introduction and objectives: Cardiovascular diseases are the leading cause of death in developed countries, and myocardial infarction is the fundamental expression. The objective of this research was to characterize the behavior and evolution of the patients treated for this disease. Method: An observational, transversal, multicentre study was performed with 31 patients who were admitted to the Comprehensive Diagnostic Center with suspected acute myocardial infarction from October 2005 to June 2007, in Trujillo State, Venezuela. The diagnosis of infarction was performed using traditional methods. Qualitative variables were analyzed using summary measures, such as the percentage. For quantitative analysis, the mean and standard deviation were used. A p ‹ 0.05 was considered significant. Results: Male sex predominated with 24 patients (77,4 %), hypertension was present in 19 (68,2 %), the highest number of cases, 19 (61,2 %) presented ST elevation and 8 patients (25,8 %) had involvement of the inferior wall, 15 (48,4 %) received fibrinolytic therapy and 11 (35,4 %) had pump failure. Predominant hospital stay was between 7 and 15 days (87 % of patients). Conclusions: Male sex and the age group between 60 and 70 years was the most representative; hypertension, dyslipidemia and diabetes mellitus were the major risk factors. Thrombolysis was performed on half of the patients that met these criteria; with optimal clinical, hemodynamic and electrical benefits.


REFERENCES

  1. Antman E, Braunwald E. Acute myocardial infarction. En: Braunwald E. Heart disease. A text book of cardiovascular medicine. 5th ed. Philadelphia: WB Saunders Co; 1997. p. 1184-1288.

  2. American Heart Association. Cardiovascular disease statisties 2006 [Internet]. [citado 7 Dic 2010]. Disponible en: http://www.americanheart.org

  3. Valladares Carvajal FJ, Iraola Ferrer MD, Nieto Prendes PR. Trombólisis tardía. Rev Cubana Cardiol Cir Cardiovas. 2000;14(2):99-106.

  4. Pfeffer MA, McMurray JJ, Velázquez EJ, Rouleau JL, Køber L, Maggioni AP, et al. Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both. N Engl J Med. 2003;349:1893-903.

  5. Triolet Gálvez IA, Sánchez MJM Rabell PO, Pino Alvarez AA. Trombólisis en pacientes con Infarto Miocárdico Agudo ingresados en una Unidad de Cuidados Intensivos. Rev Cubana Med Intens y Emerg. 2001;1(10):172-203.

  6. Loannidis JP, Salem D, Chew PW, Lau J. Accuracy and Clinical Effect of Out-of-Hospital Electrocardiography in the Diagnosis of Acute Cardiac Ischaemia: A Meta-Analysis. Ann Emerg Med. 2001;37(5): 461-70.

  7. The pre-hospital management of acute heart attacks. Recommendations of a task force of the European Society of Cardiology and the European Resuscitation Council. Eur Heart J. 1998;19(8): 1140-64.

  8. Mauro V, Charask A, Gitelman P, Salzberg S, Bruno C, Prieto N, et al. Estudio comparativo de la evolución del infarto de miocardio en los últimos 14 años en la Argentina. Conductas terapéuticas. Rev Argent Cardiol. 2001;69:591-601.

  9. Spencer B. Acute Myocardial Infarction Are diabetics different? J Am Coll Cardiol. 2000;35(3):1513-5.

  10. Piombo A, Salzberg S, Lowenberg T, Grasso C, Finaret B, Golub S, et al. Epidemiología del infarto agudo de miocardio en los hospitales públicos de la Capital Federal. Rev Argent Cardiol. 1999;67: 201-7.

  11. Boletín de Información terapéutica para APS: Boletín No. 10. CDF 1999.

  12. Hernández Cañero A .Morbimortalidad por infarto agudo del miocardio. Rev Cubana Cardiol Cir Cardiovasc. 1999;13(1):8-12.

  13. White HD, Cross DB, Williams BF, Norris RM. Safety and efficacy of report a trombolitic treatment after acute myocardial infarction. Br Heart J. 2000; 64(3):174-81.

  14. Dzavík V, Burton JR, Kee C, Teo KK, Ignaszewski A, Lucas AR, et al. Changing practice in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients. Can J Cardiol. 1998;14 (7):923-30.

  15. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med. 2005;353;1124-33.

  16. Conti R. Ischemic heart disease. JACC. 2000;35 (5):2-3.

  17. Camici PG, Crea F. Coronary Microvascular Dysfunction. N Engl J Med. 2007; 356:830-8.

  18. Organización Panamericana de la Salud. Enfermedades cardiovasculares en especial la hipertensión arterial. Washington, D.C: OPS; 2000.

  19. American Heart Association. Heart and stroke facts: 2000 statistical supplement. Dallas: AHA; 2000.p. 1- 23.

  20. Ministerio de Salud y Desarrollo Social. Anuario Nacional de Estadística Venezuela. Tasas; 2003.

  21. Sánchez Galafet C, Arguelles Mederos T, Vázquez Vázquez L, Rosadón Mc Calla Y. Importancia del Tratamiento en Sulfato de Magnesio en pacientes con infarto agudo del miocardio. Estudio preliminar. Rev Cubana Med [Internet]. 2003 [citado 2 Mar 2011];42(3):[aprox. 5 p.]. Disponible en: http://bvs.sld.cu/revistas/med/vol42_3_03/med0430 3.htm

  22. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA. Guidelines for the management ST elevation Myocardial infarction – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation. 2004;110(5):588-636.

  23. Libby P, Theroux P .Pathophysiology of coronary artery disease. Circulation. 2005; 111(25):3481-8.

  24. Hillis LD , Lange RA . Myocardial infarction and the open-artery. Hypothesis. N Engl J Med. 2005; 355(23):1124-33.

  25. Wang K, Asinger RW, Marriot HJL . ST-Segment Elevation in Conditions Other than Acute Myocardial Infarction. N Engl J Med. 2003;349:2128-34.

  26. Farreras Valenti P. Tratado de Medicina Interna [CD]. El infarto agudo del miocardio. Madrid: Doyma; 2000.

  27. Gómez PMV, Toledo Queseda A, Castellanos Dumois A, Herrera ML. Trombolisis en el infarto agudo del miocardio. Análisis de los Tiempos de demora. Rev Cubana Med [Internet]. 2001 [citado 4 Mayo 2010];40(2):[aprox. 5 p.]. Disponible en: http://bvs.sld.cu/revistas/med/vol41_5_02/med0650 2.htm

  28. Hansson GK. Inflammation, Atheroesclerosis, and Coronary Artery Disease. N Engl J Med 2005; 352: 1685-93.

  29. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, et al . Intraplaque Hemorrhage and Progression of Coronary Atheroma. N Engl J Med. 2003;349(24):2316-25.

  30. Keeley EC, Hillis D. Primary PCI for Myocardial Infarction with ST segment Elevation. N Engl J Med. 2007;356:47-52.

  31. Ross AM, Molhoek P, Lundergan C, Knudtson M, Draoui Y, RegaladoL, et al. Randomized comparison of enoxaparin, a low molecular-weight heparin, with unfractionated heparin adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin: Second trial of Heparin and Aspirin Reperfusion Therapy (HART II). Circulation 2001; 104(6):648-52.




2020     |     www.medigraphic.com